본문 바로가기

분류 전체보기

 (819)
Amyotrophic Lateral Sclerosis Market Trends and Growth Analysis As per the DelveInsight, the Amyotrophic Lateral Sclerosis prevalent population was 70,456 in 2017 in the seven major markets (i.e the USA, EU5, and Japan). In 2017, the Amyotrophic Lateral Sclerosis Market Size in 7MM was found to be USD 233.45 Million, which is expected to increase during the forecast period. Some of the key factors such as Availability of genuine epidemiological data, robust ..
Key Pharmaceutical Companies in the Venous Thromboembolism Market According to the CDC, Venous Thromboembolism affects about 900,000 people (1 to 2 per 1,000) each year in the United States, however, the exact number is unknown; with around 60,000-100,000 deaths. It is observed that nearly one-third to one-half of the affected Deep vein thrombosis patients develop long-term complications due to damages in the valves due to clots. The Venous Thromboembolism tre..
Top Pharmaceutical Companies Worldwide By Revenue The healthcare industry is witnessing significant growth with the rising demand for effective and standard healthcare services and treatments, a shift in demographic dividend, soaring healthcare expenditure, and a focus towards leading a healthy lifestyle that has been recently fuelled by the COVID19 pandemic. The global healthcare spending in 2020 was USD 8.3 trillion and it is expected to incr..
Duchenne Muscular Dystrophy Therapeutic Trials As per DelveInsight, the Duchenne Muscular Dystrophy Market is expected to achieve more than 8,000 million in revenue in the 7 Major Market (i.e. the United States, Germany, France, Italy, Spain, UK, and Japan) by the year 2030, owing to the launch of recent exon-skipping therapies along with expected approvals of the emerging therapies. The side effect associated with Steroids with the current ..
Leading Medical Drone Delivery Companies To utilize the application of drones, today, several startups are exploring the potential of drones in the healthcare segment to safely transport medical material in remote, hard-to-reach geographies, and congested urban areas. However, despite several benefits, social acceptance and the lack of appropriate drone regulation is the key challenge in the widespread use. Currently, the leading playe..
Von Hippel-Lindau Therapeutics Market According to the NORD, Von Hippel-Lindau (VHL) disease affects 1 in 36,000 people. As per DelveInsight’s analysis, the total US Von Hippel-Lindau disease prevalence was 9.2 thousand in 2020. Von Hippel-Lindau Market is expected to expand at a CAGR of 8.3% by 2030 in the 7MM owing to the increasing prevalence and emerging therapies. Due to the rarity of the condition, the therapies would be eligi..
Virtual Clinical Trials Future outlook The virtual clinical trial is one of the growing concepts in the healthcare sector getting significant attention owing to various benefits that they bring forth with them as compared to the conventional model. Virtual clinical trials (VCT) or Remote/ Decentralized Clinical Trials are a way to conduct clinical trials with the help of digital health technologies (such as apps, electronically monit..
Major Depressive Disorder Market Analysis, Clinical Trials and Prevalence Major Depressive Disorder (MDD) also called mood disorder leads to a persistent feeling of sadness and often interferes with the daily life activity of the affected person. As per the DelveInsihgt, Major Depressive Disorder Prevalence was approximated to be 43,845,330 in the 7MM in 2020, which is on a gradual rise. Globally, some of the key companies are exploring novel therapies for the treatme..

티스토리툴바